Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions

PURPOSE: To develop and validate a radiomics nomogram for the prediction of clinically significant prostate cancer (CsPCa) in Prostate Imaging-Reporting and Data System (PI-RADS) category 3 lesions. METHODS: We retrospectively enrolled 306 patients within PI-RADS 3 lesion from January 2015 to July 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tianping, Sun, Linna, Li, Qinghe, Luo, Xunrong, Luo, Mingfang, Xie, Haizhu, Wang, Peiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825569/
https://www.ncbi.nlm.nih.gov/pubmed/35155214
http://dx.doi.org/10.3389/fonc.2021.825429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825569/
https://www.ncbi.nlm.nih.gov/pubmed/35155214
http://dx.doi.org/10.3389/fonc.2021.825429

Ejemplares similares